ArticleJournal of pharmaceutical sciences2018

Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman Primates.

Simone Perazzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.